Please assess the completion status of the following clinical trial:

Trial Title: fMRI Guided TMS Enhancement of Associative Memory Networks

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Fluent in English~* Right-handed~* Score at least 26 out of 30 on the Montreal Cognitive Assessment (MOCA). Healthy subjects will be matched to age, handedness, and education compared to epilepsy subjects.~* Must be able to provide informed consent.~Exclusion Criteria:~* Any history of a neurological disorder~* Chronic or progressive medical condition~* Any history of severe traumatic brain injury or skull defect~* Metal or devices in the head, including neurostimulators of metal foreign bodies~* Any other implanted metal device, including pacemaker, spinal cord stimulator, VNS.~* Any other ferromagnetic substance in the body (including tattoos, dental prosthetics, etc).~* Taking a medication which may lower the seizure threshold within the 4 weeks prior to the start of the study, including use of neuroleptic (esp. clozapine), antibiotic (penicillin, cephalosporins), and bronchodilating medications.~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Healthy Subjects (Type: ACTIVE_COMPARATOR): None
- Temporal Lobe Epilepsy Patients (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).